Estudio comparativo del control cistoscópico vs control radiológico para el tratamiento endoscópico del megauréter obstructivo primario / Comparative study of cystoscopic control vs. radiological control in the endoscopic treatment of primary obstructive megaurater

Objetivo: La dilatación neumática con balón de alta presión para el tratamiento del megauréter obstructivo primario (MOP) fue descrita inicialmente bajo control cistoscópico y radioscópico. Sin embargo, algunos grupos utilizan únicamente el control cistoscópico, con la intención de evitar la radiación ionizante asociada al procedimiento. Material y métodos: Estudio retrospectivo que incluye los MOP tratados mediante dilatación neumática en nuestro servicio entre 2008 y 2021. Comparamos tasa de éxito, complicaciones y seguimiento entre dos grupos: dilatación bajo control cistoscópico exclusivo (CS) vs control radioscópico exclusivo (RX). Resultados: Intervenimos 23 pacientes: 9 CS y 14 RX. Ambos grupos fueron demográficamente comparables. La estancia media hospitalaria fue significativamente menor en el grupo CS (1 vs 2 días; p0,009). El tiempo quirúrgico fue mayor en el grupo RX (78 vs 30 min; p0,001). La dilatación de la unión vesicoureteral (UVU) fue satisfactoria 100% CS vs 79% RX: RR 3,87 (0,51-26,99). Las complicaciones postoperatorias fueron similares para ambos grupos, RR 3,87 (0,51-26,99). La migración del catéter doble J ocurrió en un caso en ambos grupos: RR 0,64 (0,05-9,03). A largo plazo, la tasa de éxito del tratamiento fue mayor para el grupo CS (100% vS 71%); RR 3,87 (0,51-26,99). Conclusión: La dilatación neumática del MOP bajo control cistoscópico exclusivo es más rápida de realizar, sin aumentar por ello el riesgo de complicaciones. Basándonos en nuestra experiencia, proponemos eliminar la radiación ionizante a los pacientes durante el procedimiento, ya que la consideramos innecesaria.(AU)

Objective: High-pressure balloon pneumatic dilatation for the treatment of primary obstructive megaureter (POM) was initially described under cystoscopic and radiological control. However, some groups use cystoscopic control only, in an attempt to avoid the ionizing radiation associated with the procedure. Materials and methods: A retrospective study of POM patients treated with pneumatic dilatation in our unit from 2008 to 2021 was carried out. Success rates, complications, and follow-up were compared between two groups –dilatation under cystoscopic control alone (CS) vs. dilatation under radiological control only (RX). Results: 23 patients –9 CS and 14 RX– underwent surgery. Both groups were demographically comparable. Mean hospital stay was significantly shorter in the CS group (1 vs. 2 days; p = 0.009). Operating time was longer in the RX group (78 vs. 30 min; p = 0.001). Ureterovesical junction (UVJ) dilatation was successful in 100% of CS vs. 79% of RX cases; RR: 3.87 (0.51-26.99). Postoperative complications were similar in both groups; RR: 3.87 (0.51-26.99). Double J stent migration occurred in one case in both groups; RR: 0.64 (0.05-9.03). In the long-term, treatment success rate was higher in the CS group (100% vs. 71%); RR: 3.87 (0.51-26.99). Conclusion: POM pneumatic dilatation under cystoscopic control alone is faster, without increasing the risk of complications. Based on our experience, we suggest ionizing radiation be removed, since we consider it to be unnecessary.(AU)

Comparative study of cystoscopic control vs. radiological control in the endoscopic treatment of primary obstructive megaurater. / Estudio comparativo del control cistoscópico vs control radiológico para el tratamiento endoscópico del megauréter obstructivo primario.

OBJECTIVE: High-pressure balloon pneumatic dilatation for the treatment of primary obstructive megaureter (POM) was initially described under cystoscopic and radiological control. However, some groups use cystoscopic control only, in an attempt to avoid the ionizing radiation associated with the procedure. MATERIALS AND METHODS: A retrospective study of POM patients treated with pneumatic dilatation in our unit from 2008 to 2021 was carried out. Success rates, complications, and follow-up were compared between two groups -dilatation under cystoscopic control alone (CS) vs. dilatation under radiological control only (RX). RESULTS: 23 patients -9 CS and 14 RX- underwent surgery. Both groups were demographically comparable. Mean hospital stay was significantly shorter in the CS group (1 vs. 2 days; p = 0.009). Operating time was longer in the RX group (78 vs. 30 min; p = 0.001). Ureterovesical junction (UVJ) dilatation was successful in 100% of CS vs. 79% of RX cases; RR: 3.87 (0.51-26.99). Postoperative complications were similar in both groups; RR: 3.87 (0.51-26.99). Double J stent migration occurred in one case in both groups; RR: 0.64 (0.05-9.03). In the long-term, treatment success rate was higher in the CS group (100% vs. 71%); RR: 3.87 (0.51-26.99). CONCLUSION: POM pneumatic dilatation under cystoscopic control alone is faster, without increasing the risk of complications. Based on our experience, we suggest ionizing radiation be removed, since we consider it to be unnecessary.

OBJETIVO: La dilatación neumática con balón de alta presión para el tratamiento del megauréter obstructivo primario (MOP) fue descrita inicialmente bajo control cistoscópico y radioscópico. Sin embargo, algunos grupos utilizan únicamente el control cistoscópico, con la intención de evitar la radiación ionizante asociada al procedimiento. MATERIAL Y METODOS: Estudio retrospectivo que incluye los MOP tratados mediante dilatación neumática en nuestro servicio entre 2008 y 2021. Comparamos tasa de éxito, complicaciones y seguimiento entre dos grupos: dilatación bajo control cistoscópico exclusivo (CS) vs control radioscópico exclusivo (RX). RESULTADOS: Intervenimos 23 pacientes: 9 CS y 14 RX. Ambos grupos fueron demográficamente comparables. La estancia media hospitalaria fue significativamente menor en el grupo CS (1 vs 2 días; p 0,009). El tiempo quirúrgico fue mayor en el grupo RX (78 vs 30 min; p 0,001). La dilatación de la unión vesicoureteral (UVU) fue satisfactoria 100% CS vs 79% RX: RR 3,87 (0,51-26,99). Las complicaciones postoperatorias fueron similares para ambos grupos, RR 3,87 (0,51-26,99). La migración del catéter doble J ocurrió en un caso en ambos grupos: RR 0,64 (0,05-9,03). A largo plazo, la tasa de éxito del tratamiento fue mayor para el grupo CS (100% vS 71%); RR 3,87 (0,51-26,99). CONCLUSION: La dilatación neumática del MOP bajo control cistoscópico exclusivo es más rápida de realizar, sin aumentar por ello el riesgo de complicaciones. Basándonos en nuestra experiencia, proponemos eliminar la radiación ionizante a los pacientes durante el procedimiento, ya que la consideramos innecesaria.

A novel ex vivo Huntington's disease model for studying GABAergic neurons and cell grafts by laser microdissection.

Organotypic brain slice cultures have been recently used to study neurodegenerative disorders such as Parkinson's disease and Huntington's disease (HD). They preserve brain three-dimensional architecture, synaptic connectivity and brain cells microenvironment. Here, we developed an innovative model of Huntington's disease from coronal rat brain slices, that include all the areas involved in the pathology. HD-like neurodegeneration was obtained in only one week, in a single step, during organotypic slice preparation, without the use of neurotoxins. HD-like histopathology was analysed and after one week, a reduction of 40% of medium spiny neurons was observed. To analyse new therapeutic approaches in this innovative HD model, we developed a novel protocol of laser microdissection to isolate and analyse by RT-qPCR, grafted cells as well as surrounding tissue of fresh organotypic slices. We determined that laser microdissection could be performed on a 400µm organotypic slice after alcohol dehydration protocol, allowing the analysis of mRNA expression in the rat tissue as well as in grafted cells. In conclusion, we developed a new approach for modeling Huntington's disease ex vivo, and provided a useful innovative method for screening new potential therapies for neurodegenerative diseases especially when associated with laser microdissection.